Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Acromegaly
Interventions
DRUG

Somatuline Autogel (lanreotide acetate)

Injections

BEHAVIORAL

Home administration

Questionnaire

Trial Locations (13)

10010

NYU School of Medicine, New York

10032

Columbia University, New York

14221

Sisters of Charity Hospital, Buffalo, Williamsville

21287

Johns Hopkins University, Baltimore

60611

Northwestern University The Feinberg School of Medicine, Chicago

75231

Research Institute of Dallas, Dallas

77030

Baylor College of Medicine, Houston

77230

University of Texas M.D. Anderson Cancer Center, Houston

80220

Denver VA Medical Center, Denver

90048

Cedars Sinai Medical Center, Los Angeles

91942

Diabetes and Endocrine Associates, La Mesa

97239

Oregon Health and Science University, Portland

02114

Massachussetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY